TSS
CNTX icon

Two Sigma Securities’s Context Therapeutics CNTX Stock Holding History

Two Sigma Securities’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34K Buy
61,444
+48,871
+389% +$99.1K ﹤0.01% 1430
2026
Q1 		$32.9K Buy
+12,573
New +$29.4K ﹤0.01% 1313
2023
Q1 		– Sell
-19,350
Closed -$12.6K – 2744
2022
Q4 		$12.6K Sell
19,350
-5,498
-22% -$5.92K ﹤0.01% 2333
2022
Q3 		$28K Buy
+24,848
New +$44.7K ﹤0.01% 2263

Other funds holding CNTX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Two Sigma Securities's CNTX Position: Q2 2026 in Review

Two Sigma Securities increased its Context Therapeutics (CNTX) stake by 389% in Q2 2026, buying an estimated $99.1K and bringing the position to 61,444 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Two Sigma Securities first reported a position in CNTX in Q3 2022 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Two Sigma Securities held 61,444 shares of Context Therapeutics worth $34K as of Q2 2026.
  • Two Sigma Securities bought 48,871 Context Therapeutics shares in Q2 2026, an estimated $99.1K.
  • Context Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1430 holding.
  • Two Sigma Securities first reported a position in Context Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • 79 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.